Royal Melbourne Hospital — Parkville, Victoria

Public research footprint of Royal Melbourne Hospital, compiled from the ClinicalTrials.gov public registry.

483

Registered studies

128

Active

Recruiting now

283

Completed

Stopped or withdrawn

Most-studied conditions

Huntington's Disease (HD) · NSCLC (Non-small Cell Lung Cancer) · Niemann-Pick Type C Disease · Ischemic Stroke; Ischemic Attack, Transient

Recently updated registry entries

NCT04924075 — Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL)… (Recruiting)
NCT07623525 — DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia (Recruiting)
NCT06012240 — A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Royal Melbourne Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.